493-500. 225. Kotsiari, A., Voss, E. V., Pul, R., Skripuletz, T., Ragancokova, D., Trebst, C., and Stangel, M. (2010). Interferon-beta treatment normalises the inhibitory effect of serum from multiple sclerosis
Neurol 2020;19(6):482-484 DOI: S1474-4422(20)30150-2 Mohn N, Pul R, Kleinschnitz C, Pruss H, Witte T, Stangel M, Skripuletz T. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Pat [...] 1007/s00115-020-00939-4 Mohn N, Saker F, Bonda V, Respondek G, Bachmann M, Stoll M, Wattjes MP, Stangel M, Skripuletz T. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methy [...] 8;1-5 DOI: 10.1007/s40629-020-00157-z Mohn N, Konen F F, Pul R, Kleinschnitz C, Pruss H, Witte T, Stangel M, Skripuletz T. Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: